SCHEMBL31660119

SCHEMBL31660119

NC(=O)c1cccnc1CC1CCOCC1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SYK P43405 5/20 0.45
CNR1 P21554 2/20 0.43
CNR2 P34972 2/20 0.43
GCK P35557 2/20 0.42
KCNH2 Q12809 1/20 0.42
ATM Q13315 1/20 0.42
ATR Q13535 1/20 0.42
PARP1 P09874 1/20 0.41
IRAK4 Q9NWZ3 1/20 0.40
HSD11B1 P28845 1/20 0.40
AURKA O14965 1/20 0.39
RPS6KB1 P23443 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
OPRL1 P41146 1/20 0.39
BRS3 P32247 1/20 0.38
GRM4 Q14833 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5077143 1.00 SYK (0.45) SYKCNR1CNR2GCKKCNH2
SCHEMBL31678664 0.90 PARP1 (0.46) SYKPARP1KDM4EALDH1A1HPGD
SCHEMBL22583344 0.90 PARP1 (0.46) SYKPARP1KDM4EALDH1A1HPGD
SCHEMBL31377869 0.86 SYK (0.43) SYKCNR1CNR2GCKKCNH2
SCHEMBL3429182 0.86 PARP1 (0.43) SYKCNR1CNR2GCKKCNH2
SCHEMBL4179466 0.86 PARP1 (0.43) SYKCNR1CNR2GCKKCNH2
SCHEMBL14334795 0.78 IRAK4 (0.56) IRAK4GRM4
SCHEMBL30314024 0.78 IRAK4 (0.56) IRAK4GRM4
SCHEMBL3672284 0.78 CNR1 (0.46) CNR1CNR2GCKKCNH2ATM
SCHEMBL15389531 0.77 KDM4E (0.42) CNR1CNR2KCNH2ATMATR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250230155-A1 7,8-DIHYDRO-5H-1,6-NAPHTHYRIDINE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS VANDERBILT UNIVERSITY 2025-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250230155-A1 7,8-DIHYDRO-5H-1,6-NAPHTHYRIDINE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS CHRM5, CHRM4, CHRM1 SYK 3848/4885CNR1 36/4885CNR2 126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.